MSDS of Methyl Perfluorobutylisobutyl Ether
MSDS of Methyl Perfluorobutylisobutyl Ether
MSDS of Methyl Perfluorobutylisobutyl Ether
2. HAZARDS IDENTIFICATION
GHS classification
PHYSICAL HAZARDS Not hazardous
HEALTH HAZARDS
Eye Contact: Contact with the eyes during product use is not expected to result in significant
irritation.
Skin Contact: Contact with the skin during product use is not expected to result in significant
irritation.
Inhalation: If thermal decomposition occurs, may be harmful if inhaled.
Ingestion: No health effects are expected.
3. COMPOSITION/INFORMATION ON INGREDIENTS
Substance/mixture: Mixture
Components: Methyl Perfluorobutyl Ether
CAS Number: 163702-07-6
Percent: 20%-80%
5. FIRE-FIGHTING MEASURES
Suitable extinguishing media: Material will not burn.
Precautions for firefighters: Water may be used to blanket the fire. Exposure to extreme heat can
give rise to thermal decomposition.Wear self-containing breathing
apparatus(SCBA). Wear suitable protective equipment.
Hydrogen Fluoride has an ACGIH Threshold Limit Value of 3 parts per million (as fluoride)as a Ceiling
Limit and an OSHA PEL of 3ppm of fluoride as an eight hour Time-Weighted Average and 6 ppm of fluoride as
a Short Term Exposure Limit. The odor threshold for HF is 0.04 ppm, providing good warning properties for
exposure.
Decompostion of this product at temperatures above 300 degrees C can form perfluoroisobutylene (PFIB),
but PFIB will only accumulate with continuous exposure to excessive heat in a sealed vessel. The formation rate
for PFIB is about 1000 times less than the rate for primary thermal decomposition products such as HF. During
normal use conditions, no health hazard is associated with the use of this material due to PFIB exposure.
11. TOXICOLOGICAL INFORMATION
SUMMARY OF TOXICITY DATA FOR THE METHYL PERFLUOROBUTYL ETHER AND METHYL
PERFLUOROISOBUTYL ETHER COMPONENTS:
Acute Inhalation Lethal Concentration: >100,000 ppm (rat, 4-hour)
Oral Toxicity: Practically Non-Toxic (LD50>5 g/kg in rat)
Developmental Toxicity: No abnormal effects observed.
Mutagenicity: Not a mutagen in reverse mutation or chromosomal aberration assay
Cardiac Sensitization: No signs of sensitization at exposures up to 100,000 ppm.
Primary Dermal Irritation: Minimally irritating.
Primary Ocular Irritation: Practically non-irritating.
Dermal Sensitization: Not a skin sensitizer
90 Day Inhalation Study in rats: NOEL=7500 ppm
Dermal Absorption ( 5 daily applications in rabbits): Not a significant route of exposure.